Not Yet Recruiting EARLY_PHASE1 INTERVENTIONAL 1-arm
NCT06646783
Phase IIT Trial of SNA014
Clinical Study of 68GA-labeled Claudin 18.2 Developer Combined with PET/CT for Imaging of Gastric or Gastroesophageal Junction Adenocarcinoma and Pancreatic Cancer
Sponsor: SmartNuclide Biopharma
Interventions
[68Ga]Ga-NODAGA-SNA014
Updated 1 time since 2024 Last updated: Oct 15, 2024 Started: Oct 20, 2024 Primary completion: Oct 20, 2025 Completion: Nov 20, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A EARLY_PHASE1 clinical study on Adenocarcinoma of GE Junction and Adenocarcinoma of the Stomach, this trial is actively recruiting participants. The trial is conducted by SmartNuclide Biopharma and has accumulated 1 data snapshot since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — EARLY_PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- SmartNuclide Biopharma
Data source: SmartNuclide Biopharma
For direct contact, visit the study record on ClinicalTrials.gov .